Thoracic aortic wall

The thoracic aortic wall is an anatomical structure, specifically a structural component of the cardiovascular system. It is composed of three histological layers: the intima, media, and adventitia. In the context of drug development and biotech, the thoracic aortic wall itself is not considered a therapeutic target. Therapeutic targets are typically specific molecules such as receptors, enzymes, transporters, or other proteins that can be modulated by drugs. While various molecular factors involved in thoracic aortic diseases (e.g., matrix metalloproteinases, TGF-β, inflammatory cytokines) can serve as therapeutic targets, the aortic wall is the affected structure, not the target molecule. Therefore, it is categorized as 'is_incorrect: true' for a therapeutic target.